Literature DB >> 2423266

Epidermoid metaplasias of xenotransplanted human tracheobronchial epithelium.

A J Klein-Szanto, M Baba, D Trono, T Obara, J Resau, B F Trump.   

Abstract

Repopulation of rat tracheas of human tracheobronchial epithelial cells obtained from intermediate autopsies was achieved by introducing into de-epithelialized rat tracheas either pieces of donor tissue containing respiratory mucosa or epithelial cells produced by an in vitro amplification of these cells. After tracheas were sealed, and transplanted into the subcutaneous tissues of nude mice, a newly formed epithelium migrated over the denuded luminal surface. During this process, regenerative epidermoid metaplasias, consisting of the growth of thin stratified epithelium with keratinization but without atypia was observed. Four weeks after xenotransplantation, most of the luminal surface was covered by columnar epithelium with occasional patches of epidermoid metaplasia. When this epithelium was exposed to 7,12-dimethylbenzo[a]anthracene (DMBA) a thick epidermoid metaplasia with mild to moderate atypia was observed. This type of epithelium is seen one to three months after insertion of the DMBA-containing pellets into the tracheal lumen. Immunohistochemical staining with antikeratin monoclonal antibodies AE1 and AE3 revealed increased immunostaining in both regenerative and DMBA-induced metaplasias compared with that of untreated normal mucociliary epithelium. Although no differences between the two types of metaplasias were detected with AE1 and AE3, the use of involucrin immunostain showed important differences. Normal respiratory epithelium did not contain involucrin, but this protein was seen in the surface layer of regenerative epidermoid metaplasias. In DMBA-induced metaplasias, involucrin was found not only in the superficial cells but was also present in numerous suprabasal cells. The hyperplastic nature of these carcinogen-induced lesions, together with the presence of cellular atypia and an altered involucrin distribution pattern, suggest a preneoplastic state.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423266     DOI: 10.1093/carcin/7.6.987

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Discrimination of normal and transformed cells in vitro by cytologic and morphologic analysis.

Authors:  C D Albright; R Hay; R T Jones; J H Resau
Journal:  Cytotechnology       Date:  1989-08       Impact factor: 2.058

2.  Effects of formaldehyde on normal xenotransplanted human tracheobronchial epithelium.

Authors:  H Ura; P Nowak; S Litwin; P Watts; R D Bonfil; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

3.  In vitro and in vivo growth and differentiation of clones of tracheal basal cells.

Authors:  Y Inayama; G E Hook; A R Brody; A M Jetten; T Gray; J Mahler; P Nettesheim
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

4.  p53 alterations in human squamous cell carcinomas and carcinoma cell lines.

Authors:  J Caamano; S Y Zhang; E A Rosvold; B Bauer; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

5.  Localization of keratin mRNA in human tracheobronchial epithelium and bronchogenic carcinomas by in situ hybridization.

Authors:  T Obara; M Baba; Y Yamaguchi; E Fuchs; J H Resau; B F Trump; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

Review 6.  Multistep process of squamous differentiation in tracheobronchial epithelial cells in vitro: analogy with epidermal differentiation.

Authors:  A M Jetten
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

7.  Resistance to serum-induced terminal differentiation in normal human tracheobronchial epithelial cells after in vivo exposure to 7,12-dimethylbenz[a]anthracene.

Authors:  M Baba; T Obara; R D Bonfil; Y Yamaguchi; B F Trump; J Resau; A J Klein-Szanto
Journal:  Jpn J Cancer Res       Date:  1988-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.